162 related articles for article (PubMed ID: 19082900)
1. Commentary: current advances and future directions for CNS delivery.
Svensson CK; Scherrmann JM
AAPS J; 2008 Dec; 10(4):587-8. PubMed ID: 19082900
[No Abstract] [Full Text] [Related]
2. Delivery of therapeutic molecules into the CNS.
Emborg ME; Kordower JH
Prog Brain Res; 2000; 128():323-32. PubMed ID: 11105691
[No Abstract] [Full Text] [Related]
3. Prodrug approaches to reduce hyperexcitation in the CNS.
Vytla D; Combs-Bachmann RE; Hussey AM; McCarron ST; McCarthy DS; Chambers JJ
Adv Drug Deliv Rev; 2012 May; 64(7):666-85. PubMed ID: 22138074
[TBL] [Abstract][Full Text] [Related]
4. Prodrug approaches for CNS delivery.
Rautio J; Laine K; Gynther M; Savolainen J
AAPS J; 2008; 10(1):92-102. PubMed ID: 18446509
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the mechanism of enhancement of central nervous system delivery of 2'-beta-fluoro-2',3'-dideoxyinosine via a blood-brain barrier adenosine deaminase-activated prodrug.
Johnson MD; Chen J; Anderson BD
Drug Metab Dispos; 2002 Feb; 30(2):191-8. PubMed ID: 11792690
[TBL] [Abstract][Full Text] [Related]
6. Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
Patching SG
Mol Neurobiol; 2017 Mar; 54(2):1046-1077. PubMed ID: 26801191
[TBL] [Abstract][Full Text] [Related]
7. Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport).
Terasaki T; Pardridge WM
J Drug Target; 2000; 8(6):353-5. PubMed ID: 11328661
[No Abstract] [Full Text] [Related]
8. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS.
Perioli L; Ambrogi V; Bernardini C; Grandolini G; Ricci M; Giovagnoli S; Rossi C
Eur J Med Chem; 2004 Aug; 39(8):715-27. PubMed ID: 15276305
[TBL] [Abstract][Full Text] [Related]
9. Applications of nanotechnology in drug delivery to the central nervous system.
Saeedi M; Eslamifar M; Khezri K; Dizaj SM
Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery to the CNS.
Khosa A; Singhvi G; Saha RN; Gupta G
Panminerva Med; 2018 Dec; 60(4):226. PubMed ID: 29856182
[No Abstract] [Full Text] [Related]
11. Fluorinated molecules as drugs and imaging agents in the CNS.
Sun S; Adejare A
Curr Top Med Chem; 2006; 6(14):1457-64. PubMed ID: 16918461
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of biologics to the central nervous system.
Lochhead JJ; Thorne RG
Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
[TBL] [Abstract][Full Text] [Related]
13. Intranasal drug delivery to the central nervous system: present status and future outlook.
Tayebati SK; Nwankwo IE; Amenta F
Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
[TBL] [Abstract][Full Text] [Related]
14. Current approaches for drug delivery to central nervous system.
Hossain S; Akaike T; Chowdhury EH
Curr Drug Deliv; 2010 Dec; 7(5):389-97. PubMed ID: 20950269
[TBL] [Abstract][Full Text] [Related]
15. Pericytes and the blood-brain barrier: recent advances and implications for the delivery of CNS therapy.
Armulik A; Mäe M; Betsholtz C
Ther Deliv; 2011 Apr; 2(4):419-22. PubMed ID: 22826851
[TBL] [Abstract][Full Text] [Related]
16. Peptide drug delivery into the central nervous system.
Prokai L
Prog Drug Res; 1998; 51():95-131. PubMed ID: 9949860
[TBL] [Abstract][Full Text] [Related]
17. CNS-delivery via conjugation to biological carriers: physiological-based approaches.
Vyas SP
Prog Drug Res; 2003; 61():189-219. PubMed ID: 14674613
[No Abstract] [Full Text] [Related]
18. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
19. Delivery of therapeutics to the central nervous system.
Chambers JJ
Adv Drug Deliv Rev; 2012 May; 64(7):589. PubMed ID: 22388004
[No Abstract] [Full Text] [Related]
20. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
